Moleculin Biotech, Inc. (MBRX)
Insiders here have filed 4 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
No revenue reported, so there is no margin to score.
- Revenue
- $0
- Net income
- -$30.3M
- Net margin
- —
Little or no net debt.
- Total debt
- $292K
- Cash
- $7.3M
- Debt / equity
- 0.03
Owes more within a year than it holds to pay it.
- Current assets
- $8.7M
- Current liabilities
- $9.3M
- Current ratio
- 0.94
Consumes cash and must keep raising it.
- Operating cash flow
- -$25.4M
- Free cash flow
- -$25.4M
Burning cash with under a year of runway — expect a raise.
- Shares outstanding
- 0.3M
- Share growth (1y)
- 814.7%
- Cash runway
- 3 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
MBRX Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | 0.00 | 8.00 K | 0.00 | 0.00 | 29.00 K | 0.00 |
| Gross Profit | 0.00 | -8.00 K | 0.00 | 0.00 | -29.00 K | 0.00 |
| SG&A Expense | 2.10 M | 2.49 M | 2.41 M | 2.15 M | 2.09 M | 2.48 M |
| R&D Expense | 5.45 M | 5.38 M | 5.12 M | 3.74 M | 3.60 M | 3.44 M |
| Operating Expenses | 7.56 M | 7.87 M | 7.53 M | 5.91 M | 5.69 M | 5.94 M |
| Operating Income | -7.56 M | -7.87 M | -7.53 M | -5.91 M | -5.72 M | -5.94 M |
| Pretax Income | -7.63 M | -12.85 M | 15.55 M | -25.40 M | -7.64 M | -6.44 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -7.63 M | -12.85 M | 15.55 M | -25.40 M | -7.64 M | -6.44 M |
| EPS (Basic) | -28.00 | -70.80 | 96.60 | -340.40 | -246.00 | -316.00 |
| EPS (Diluted) | -28.00 | -70.80 | 96.60 | -340.40 | -246.00 | -316.00 |
| Shares Outstanding | 284.04 K | 206.22 K | 159.96 K | 74.61 K | 31.05 K | 18.69 K |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.